The Movement Disorders Unit is dedicated to providing quality care for people living with a movement disorder.  It offers specialty clinics, in-patient consultations, clinical trial opportunities and multi-disciplinary support services.

Around 100,000 Australians are living with a diagnosis of Parkinson’s disease. It is the second most common neurological disease in Australia after dementia. Whilst it is largely diagnosed in older people, one in five patients will receive the diagnosis before the age of 50. At present there are a number of therapies which improve the symptoms of Parkinson’s but no disease modifying therapies. The movement disorders team at the Royal Melbourne hospital is involved in a number of clinical trials for Parkinson’s disease, including early phase interventional studies looking at possible disease modifying strategies.


Dr Andrew Evans - Profile Pic.jpeg

Dr Andrew Evans


Dr Andrew Evans has been the director of the Movement Disorders service at the Royal Melbourne Hospital for 15 years. During this time, he has built a team that endeavours to deliver evidence-based care for movement disorders patients, including a range of device-aided therapies, deep brain stimulation and pump therapies.

After completing his Neurology training at The Royal Melbourne Hospital, Andrew embarked on a fellowship in movement disorders at the National Hospital for Neurology and Neurosurgery, Queens Square, London. He was awarded the Doctor of Medicine (MD) by University College London focusing on the neuropsychiatric complications of Parkinson’s disease, and utilises these specialty skills with an ongoing consultative role with the Neuropsychiatry service at the Royal Melbourne Hospital.

In between delivering clinical care and fostering research initiatives, Andrew is frequently invited to speak at both local and international movement disorder educational meetings, in addition to community engagement events. He has also been the author for a number of book chapters on topics related to Parkinson’s disease, with 139 scholarly works published as well.

Christine Woods.jpg

Dr Christine Wools


Dr Christine Wools has completed a Masters of Philosophy with a research project in mitochondrial disease. She has an interest in Neurogenetics and atypical Parkinsonian disorders and clinical roles in the Movement disorders, Neurogenetics and Headache clinics. 

In 2021, Christine presented lectures at patient education days for the Mitochondrial disease foundation and also the Motor neurone disease workshop for health professionals. 

She was selected to participate in the International Movement Disorders Society LEAP leadership program 2020-2021, and is an executive committee member for the Movement Disorders Society of Australia and New Zealand. 

Jen Nagao.jpg

Dr Jen Nagao


Dr Jen Nagao is a Neurology consultant at The Royal Melbourne Hospital. Her roles include the coordination of the Deep Brain Stimulation surgery program, and clinical care of movement disorders patients.

Jen has completed an MBBS, FRACP, along with movement disorders fellowships at Monash Medical Centre, Royal Brisbane & Women's Hospital and Henry Ford Health System in Michigan. 

She is currently completing a Master's in Public Health.


RMH Social Media v1.0 dd 22Jun2021-FINAL_0001.jpg


Dr Andrew Evans spoke to Parkinson's Australia about the work being performed by the Movement Disorders team at the Melbourne Brain Centre (MBC) at Royal Melbourne Hospital. Click the below logo to watch a recording of this discussion on YouTube.


Dr Andrew Evans provides an introduction to the work being performed by the Movement Disorders team at the Melbourne Brain Centre (MBC) at Royal Melbourne Hospital. In particular, he discusses the work on using botox to help treat symptoms, such as tremors, in people living with multiple sclerosis.